Inventor · disambiguated record
Jagath Reddy Junutula
Also filed as: JUNUTULA JAGATH R · JUNUTULA JAGATH REDDY
34 granted patents·31 pending applications·2,547 citations·filing 2005–2023
98Inventor score
Top patents by PatentIndex Score
65 records- 0197US8545850B2Anti-CD79B antibodies and immunoconjugates and methods of useCHEN YVONNE·Filed 2010·Granted Oct 1, 2013·48 cites·8 claims
- 0297US8309300B2Cysteine engineered antibodies and conjugatesJUNUTULA JAGATH REDDY·Filed 2009·Granted Nov 13, 2012·111 cites·6 claims
- 0397US7855275B2Cysteine engineered antibodies and conjugatesGENENTECH INC·Filed 2009·Granted Dec 21, 2010·301 cites·63 claims
- 0497US7723485B2Cysteine engineered anti-MUC16 antibodies and antibody drug conjugatesGENENTECH INC·Filed 2008·Granted May 25, 2010·286 cites·40 claims
- 0597US7521541B2Cysteine engineered antibodies and conjugatesGENENTECH INC·Filed 2005·Granted Apr 21, 2009·1.4k cites·68 claims
- 0696US9518118B2Anti-HER2 antibodies and immunoconjugatesGENENTECH INC·Filed 2015·Granted Dec 13, 2016·22 cites·29 claims
- 0796US8088378B2Anti-CD79B antibodies and immunoconjugates and methods of useCHEN YVONNE·Filed 2008·Granted Jan 3, 2012·48 cites·5 claims
- 0895US9896506B2Anti-CD79B antibodies and immunoconjugates and methods of useGENENTECH INC·Filed 2015·Granted Feb 20, 2018·17 cites·27 claims
- 0995US9000130B2Cysteine engineered antibodies and conjugatesBHAKTA SUNIL·Filed 2011·Granted Apr 7, 2015·158 cites·28 claims
- 1095US8617559B2Anti-FcRH5 antibodies and immunoconjugates and methods of useGENENTECH INC·Filed 2012·Granted Dec 31, 2013·19 cites·34 claims
- 1194US8722857B2Anti-CD79B antibodies and immunoconjugates and methods of useCHEN YVONNE·Filed 2009·Granted May 13, 2014·22 cites·53 claims
- 1294US8691531B2Anti-CD79B antibodies and immunoconjugates and methods of useCHEN YVONNE·Filed 2011·Granted Apr 8, 2014·20 cites·9 claims
- 1394US8362213B2Anti-FcRH5 antibodies and immunoconjugates and methods of useGENENTECH INC·Filed 2010·Granted Jan 29, 2013·28 cites·53 claims
- 1492US10981987B2Humanized anti-CD79b antibodies and immunoconjugates and methods of useGENENTECH INC·Filed 2017·Granted Apr 20, 2021·4 cites·26 claims
- 1592US9845355B2Humanized anti-CD79b antibodies and immunoconjugates and methods of useCHEN YVONNE·Filed 2008·Granted Dec 19, 2017·20 cites·23 claims
- 1692US8466260B2Anti-FcRH5 antibodies and immunoconjugates and methods of useELKINS KRISTI·Filed 2010·Granted Jun 18, 2013·21 cites·49 claims
- 1791USRE48558EAnti-CD79B antibodies and immunoconjugates and methods of useGENENTECH INC·Filed 2018·Granted May 18, 2021·2 cites·70 claims
- 1891US9360484B2Anti-FcRH5 antibodies and immunoconjugates and methods of useGENENTECH INC·Filed 2013·Granted Jun 7, 2016·7 cites·20 claims
- 1990US10179820B2Anti-HER2 antibodies and immunoconjugatesGENENTECH INC·Filed 2016·Granted Jan 15, 2019·6 cites·26 claims
- 2089US11866496B2Humanized anti-CD79B antibodies and immunoconjugates and methods of useGENENTECH INC·Filed 2021·Granted Jan 9, 2024·1 cites·31 claims
- 2189US8937161B2Cysteine engineered anti-TENB2 antibodies and antibody drug conjugatesMAO WEIGUANG·Filed 2008·Granted Jan 20, 2015·23 cites·37 claims
- 2289US2024309088A1Anti-cd79b antibodies and immunoconjugates and methods of useGENENTECH INC·Filed 2023·Application pending·0 cites
- 2388US10544218B2Anti-CD79B antibodies and immunoconjugates and methods of useGENENTECH INC·Filed 2016·Granted Jan 28, 2020·4 cites·61 claims
- 2486US10494432B2Anti-CD79B antibodies and immunoconjugates and methods of useGENENTECH INC·Filed 2013·Granted Dec 3, 2019·5 cites·118 claims
- 2585US11072662B2Humanized anti-CLL-1 antibodiesCELLERANT THERAPEUTICS INC·Filed 2016·Granted Jul 27, 2021·2 cites·12 claims
- 2685US9017951B2Anti-FcRH5 antibodies and immunoconjugates and methods of useGENENTECH INC·Filed 2012·Granted Apr 28, 2015·7 cites·1 claims
- 2785US2024218050A1Cysteine Engineered Antibodies and ConjugatesGENENTECH INC·Filed 2023·Application pending·0 cites
- 2883US10556966B2Anti-HER2 antibodies and immunoconjugatesGENENTECH INC·Filed 2018·Granted Feb 11, 2020·2 cites·44 claims
- 2982US12492263B2Anti-HER2 antibodies and immunoconjugatesGENENTECH INC·Filed 2022·Granted Dec 9, 2025·0 cites·15 claims
- 3081US10077318B2Cysteine engineered antibodies and conjugatesGENENTECH INC·Filed 2015·Granted Sep 18, 2018·5 cites·41 claims
- 3179US10314846B2Immunoconjugates comprising anti-HER2 antibodies and pyrrolobenzodiazepinesGENENTECH INC·Filed 2017·Granted Jun 11, 2019·2 cites·64 claims
- 3276US2020247887A1Anti-cd79b antibodies and immunoconjugates and methods of useGENENTECH INC·Filed 2019·Application pending·0 cites
- 3375US11359025B2Anti-IL1-RAP antibodiesCANTARGIA AB·Filed 2017·Granted Jun 14, 2022·1 cites·17 claims
- 3475US10604557B2Cysteine engineered antibodies and conjugatesGENENTECH INC·Filed 2016·Granted Mar 31, 2020·1 cites·10 claims
- 3575US2020255539A1Anti-HER2 Antibodies and ImmunoconjugatesGENENTECH INC·Filed 2019·Application pending·0 cites
- 3672US11873330B2Cysteine engineered antibodies and conjugatesGENENTECH INC·Filed 2020·Granted Jan 16, 2024·0 cites·5 claims
- 3769US2020079852A1Anti-cd79b antibodies and immunoconjugates and methods of useGENENTECH INC·Filed 2019·Application pending·0 cites
- 3868US2018000962A1Cysteine engineered antibodies and conjugatesGENENTECH INC·Filed 2017·Application pending·0 cites
- 3966US2015017188A1Cysteine engineered antibodies and conjugatesGENENTECH INC·Filed 2014·Application pending·0 cites
- 4066US2023130874A1Cysteine Engineered Antibodies and ConjugatesGENENTECH INC·Filed 2022·Application pending·0 cites
- 4164US2014335107A1Anti-cd79b antibodies and immunoconjugates and methods of useGENENTECH INC·Filed 2014·Application pending·0 cites
- 4262US2009068178A1Compositions and Methods for the Treatment of Tumor of Hematopoietic OriginGENENTECH INC·Filed 2008·Application pending·0 cites
- 4361US2014288280A1Cysteine engineered antibodies and conjugatesGENENTECH INC·Filed 2014·Application pending·0 cites
- 4459US2015017094A1Zirconium-radiolabeled, cysteine engineered antibody conjugatesGENENTECH INC·Filed 2014·Application pending·0 cites
- 4559US2015158952A1Cysteine engineered anti-tenb2 antibodies and antibody drug conjugatesGENENTECH INC·Filed 2014·Application pending·0 cites
- 4658US2011137017A1Cysteine engineered antibodies and conjugatesEIGENBROT CHARLES W·Filed 2010·Application pending·0 cites
- 4756US2017362318A1Compositions and methods for the treatment of tumor hematopoietic originGENENTECH INC·Filed 2017·Application pending·0 cites
- 4853US2020085840A1Immunoconjugates Comprising Anti-HER2 Antibodies and PyrrolobenzodiazepinesGENENTECH INC·Filed 2019·Application pending·0 cites
- 4953US2010111856A1Zirconium-radiolabeled, cysteine engineered antibody conjugatesGILL HERMAN·Filed 2009·Application pending·0 cites
- 5052US9580514B2Compositions and methods for the diagnosis and treatment of tumorGENENTECH INC·Filed 2013·Granted Feb 28, 2017·0 cites·16 claims
Showing the top 50 of 65 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Jagath Reddy Junutula files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →